https://www.selleckchem.com/pr....oducts/alpha-cyano-4
21 (P.001), 0.16 (P .001), and 0.25 (P=.001), respectively. Of patients who develop subsequent cSCC, 18.06% do so within 6months, and 31.77% do so within 1year of initial cSCC diagnosis. Patients with advanced age, poor histologic differentiation, and American Joint Committee on Cancer T2 stage are at highest risk. Close clinical follow-up after the initial diagnosis is recommended. Of patients who develop subsequent cSCC, 18.06% do so within 6 months, and 31.77% do so within 1 year of initial c
Like
Comment
Share
